Acrivon Therapeutics, Inc. Common Stock (ACRV) NASDAQ

1.79

+0.46(+34.59%)

Updated at September 08 04:00PM

Currency In USD

Valuation

Market Cap2.03B
Enterprise Value2B
P/E Ratio-0.82
PEG Ratio0.6
Price/Sales Ratio67.69
Price/Book Ratio0.49
Enterprise/Revenue22.14
Enterprise/EBITDA-0.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-101.37
Operating Margin-111.33

Management Effectiveness

Return On Assets-0.54
Return On Equity-0.51

Income Statement

Revenue0
Revenue/Share0.02
Gross Profit-1.01M
EBITDA-79.55M
Net Income-80.56M
Diluted EPS-0.24

Balance Sheet

Total Cash137.42M
Total Cash/Share3.57
Total Debt3.26M
Total Debt/Equity0.02
Current Ratio10.31
Book Value Per Share3.72

Price History

52-Week Change-76.9
52-Week High10
52-Week Low1.05
Moving Average 50 Days1.32
Moving Average 200 Days3.4

Statistics

Average Volume355,025
Shares Outstanding31.45M
% Held by Institutions46.29

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A